Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $453,828,697.97
- Sept. 9, 2025
- Akshay Vaishnaw
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 17, 2014 | EVP | 10,625 | $69.82 | Sell | $741,837.50 | |
| May 21, 2014 | Director | 35,000 | $53.80 | Sell | $1,883,000.00 | |
| May 19, 2014 | SVP | 13,500 | $57.83 | Sell | $780,705.00 | |
| May 15, 2014 | CEO | 113,668 | $56.73 | Sell | $6,448,385.64 | |
| March 25, 2014 | major shareholder | 344,448 | $66.88 | Buy | $23,036,682.24 | |
| March 18, 2014 | EVP | 32,769 | $73.95 | Sell | $2,423,267.55 | |
| Feb. 19, 2014 | SVP | 20,400 | $80.06 | Sell | $1,633,224.00 | |
| Jan. 24, 2014 | EVP | 7,890 | $85.75 | Sell | $676,567.50 | |
| Jan. 13, 2014 | Director | 15,000 | $85.36 | Sell | $1,280,400.00 | |
| Dec. 20, 2013 | Director | 15,000 | $65.00 | Sell | $975,000.00 | |
| Dec. 17, 2013 | EVP | 33,480 | $60.72 | Sell | $2,032,905.60 | |
| Oct. 22, 2013 | Director | 15,000 | $60.00 | Sell | $900,000.00 | |
| Sept. 11, 2013 | CEO | 58,947 | $55.50 | Sell | $3,271,558.50 | |
| Sept. 10, 2013 | EVP | 6,250 | $57.48 | Sell | $359,250.00 | |
| Aug. 14, 2013 | CEO | 60,000 | $48.97 | Sell | $2,938,200.00 | |
| July 12, 2013 | VP | 14,200 | $50.00 | Sell | $710,000.00 | |
| July 10, 2013 | CEO | 60,000 | $37.11 | Sell | $2,226,600.00 | |
| July 1, 2013 | VP | 27,000 | $32.00 | Sell | $864,000.00 | |
| June 17, 2013 | VP | 23,625 | $29.93 | Sell | $707,096.25 | |
| June 11, 2013 | EVP | 15,000 | $31.08 | Sell | $466,200.00 | |
| May 28, 2013 | COO | 22,822 | $30.00 | Sell | $684,660.00 | |
| May 28, 2013 | SVP | 5,000 | $30.00 | Sell | $150,000.00 | |
| March 26, 2013 | Director | 52,631 | $23.49 | Sell | $1,236,302.19 | |
| Jan. 22, 2013 | Director | 4,967 | $20.13 | Buy | $99,985.71 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Yvonne Greenstreet, Laurie Keating, Pushkal Garg, Barry E Greene, Paul Schimmel, Michael Mason, Philip A Sharp, Tolga Tanguler, Jeffrey V Poulton, Dennis A Ausiello, Laurence Reid, Sanofi, Kevin Joseph Fitzgerald, Steven M Paul, Michael W Bonney, Kevin P Starr, Indrani Lall Franchini, Phillip A Sharp, David E I Pyott, Amy W Schulman, David-Alexandre C Gros, John Clarke, Kevin P. Starr, Marsha Fanucci, Philip A. Sharp, Phillip A. Sharp, and Colleen F Reitan
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on Sept. 9, 2025.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Pushkal Garg with a total value of $14,988,720.00 on Jan. 27, 2025.